LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Computer-Based Strategy Designed for Protein Nanomachines

By LabMedica International staff writers
Posted on 09 Jan 2019
Print article
Image: Proteins designed in the lab can now zip together in much the same way that DNA molecules zip up to form a double helix. The technique could enable the design of protein nanomachines that can potentially help diagnose and treat disease, allow for the more exact engineering of cells, and perform a wide variety of other tasks (Photo courtesy of the Institute for Protein Design, University of Washington).
Image: Proteins designed in the lab can now zip together in much the same way that DNA molecules zip up to form a double helix. The technique could enable the design of protein nanomachines that can potentially help diagnose and treat disease, allow for the more exact engineering of cells, and perform a wide variety of other tasks (Photo courtesy of the Institute for Protein Design, University of Washington).
A team of bio-molecular engineers used the Rosetta software suite to design orthogonal protein heterodimers, which are protein "nanomachines" that are expected to enable sophisticated protein-based control logic for synthetic biology applications.

In chemistry and biochemistry, an orthogonal interaction occurs when there are two pairs of substances and each substance can interact with their respective partner, but does not interact with either substance of the other pair. For example, DNA has two orthogonal pairs: cytosine and guanine form a base-pair, and adenine and thymine form another base-pair, but other base-pair combinations are strongly disfavored.

Development of the Rosetta software began in the laboratory of Dr. David Baker at the University of Washington (Seattle, USA) as a structure prediction tool but since then has been adapted to solve common computational macromolecular problems. The Rosetta software suite includes algorithms for computational modeling and analysis of protein structures. It has enabled notable scientific advances in computational biology, including de novo protein design, enzyme design, ligand docking, and structure prediction of biological macromolecules and macromolecular complexes.

Investigators at the University of Washington reported in the December 19, 2018, online edition of the journal Nature that protein–protein interaction specificity could be achieved using extensive and modular side-chain hydrogen-bond networks. They produced millions of four-helix backbones with varying degrees of supercoiling around a central axis, identified those accommodating extensive hydrogen-bond networks, and used Rosetta to connect pairs of helices with short loops and to optimize the remainder of the sequence. Of 97 such designs expressed in Escherichia coli, 65 formed constitutive heterodimers, and the crystal structures of four designs were in close agreement with the computational models and confirmed the designed hydrogen-bond networks.

"This is a first-of-its-kind breakthrough," said first author Zibo Chen, a graduate researcher in biochemistry at the University of Washington. "What we are doing is computationally designing these hydrogen-bond networks so that each protein pair has a unique complementary sequence. There is only one way for them to come together and they do not cross-react with proteins from other pairs."

"Engineering cells to do new tasks is the future of medicine and biotechnology, whether that is engineering bacteria to make energy or clean up toxic waste or creating immune cells that attack cancers," said contributing author Dr. Scott Boyken, a postdoctoral researcher at the institute for protein design at the University of Washington. "This technique provides scientists a precise, programmable way to control how protein machines interact, a key step towards achieving these new tasks. We have opened a major door to protein nanomaterial design."

Related Links:
University of Washington

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Dermatophytosis Rapid Diagnostic Kit
StrongStep Dermatophytosis Diagnostic Kit
New
Centromere B Assay
Centromere B Test

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.